Health Canada approves first human trial for experimental cancer drug

EDMONTON - Health Canada has approved the first human trial of an experimental cancer drug called dichloroacetate, or DCA, in people with an advanced form of an aggressive brain cancer. The molecule has drawn international attention after the University of Alberta's Dr....More